Nilai Perusahaan: markertherapeutics.com (MRKR)

The current market value of Marker Therapeutics (MRKR) displayed on the GURU.Markets chart is 4.42. Marker Therapeutics is scaling the application of targeted T-cell immunotherapy, moving core products into the pivotal testing stage supported by grants. The brand's high authority in oncohematology was established by the innovative MultiTAA system, which ensures the safe destruction of neoplasms. The business's financial stability currently depends on the results of clinical trials, as there is no operating income.

MRKR - Nilai Perusahaan Marker Therapeutics ing rentang 23.11.2025 - 31.10.2026

Ringkesan rincian data analitis Marker Therapeutics, Inc. (MRKR)

- kuotasi lan prakiraan analis:

Bagan owah-owahan rega Marker Therapeutics Inc|MRKR - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Kapitalisasi pasar Marker Therapeutics|MRKR - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Nilai Akuntansi Saham Marker Therapeutics|MRKR - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih markertherapeutics.com|MRKR - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Marker Therapeutics|MRKR - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal Marker Therapeutics Inc|MRKR - Gunggung utang perusahaan|Utang marang nilai buku Marker Therapeutics|MRKR - Utang jangka dawa perusahaan|Utang jangka cendhak Marker Therapeutics|Rasio jangkoan perantara markertherapeutics.com

- statistik bathi lan rasio pasar:

MRKR - Penghasilan resik

Ringkesan analitik perusahaan:MRKR - Marker Therapeutics

Investors assess business quality through the actual cost of acquiring all assets. This metric sums market capitalization with debt obligations, subtracting available cash. For Marker Therapeutics (MRKR), this metric is critical as it reflects the financial burden during the implementation of long clinical cycles. Stable demand for innovation minimizes cyclical risks. The trend of total asset value, accounting for net debt, allows for an objective assessment of the company's scale.

Karo sapa Marker Therapeutics saingan

Nilai Dipunlarasaken Utang lan Kas TGTX|ACLX - Nilai Total Perusahaan|IRON - Nilai Perusahaan|Syndax Pharmaceuticals (SNDX) - Nilai Total Perusahaan|kuraoncology.com - Nilai Dipunlarasaken Utang lan Kas|ADCT (ADC Therapeutics SA) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Foghorn (FHTX)|Nilai Perusahaan VOR|Nilai Perusahaan nkartatx.com (NKTX)|Nilai Total Perusahaan Coeptis Therapeutics, Inc. COEP|ATNM: Nilai Bisnis|Estrella Immunopharma, Inc. - Nilai Perusahaan|CASI Pharmaceuticals (CASI) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|INAB: Nilai Perusahaan|Total Nilai Perusahaan Eterna Therapeutics Inc. (ERNA)|Nilai Total Perusahaan GT Biopharma, Inc.|APTO: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh BPTH (Bio-Path Holdings, Inc.)|MEIP (MEI Pharma Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan VINC (Vincerx Pharma)